Sword Health

Phoenix performs real work rather than acting as an interface: motion tracking with real time biofeedback during exercise, and around the clock natural language support between sessions. That combination is what allows a supervised program to run without a clinician present. Held back from A because a licensed clinician remains in the loop for every member by design, and the product delivered is a care program rather than software. The company describes this explicitly, which is the right disclosure.

One of the clearest oversight structures in the index, and unusually it is described per product rather than in general. A matched licensed specialist remains in the loop for every interaction, advising on complex questions and sensitive conversations, with the specialist type adapting to the program: Doctors of Physical Therapy for musculoskeletal and lifestyle support. The AI is explicitly positioned as continuous support between clinician touchpoints rather than as a substitute for them, and the company states where human guidance takes over.

Scale is substantial and specific: more than 800,000 members, 11 million AI care sessions, over 1,000 clients, and reported per member savings of $3,177 a year for the musculoskeletal program with customer avoided costs exceeding $1 billion. The company also cites peer reviewed research finding high intensity digital physical therapy as effective as clinic based care, which is the right comparison to make. Held back from A because the economic figures are vendor calculated without published methodology, and the cited peer reviewed work supports the modality rather than this vendor's specific implementation.

Structure is disclosed even though amounts are not, and the structure is the interesting part: the company sells as an employer and health plan benefit and states that Pulse carries outcomes based pricing, meaning the vendor takes financial risk against results. Third party coverage indicates risk sharing arrangements more broadly. A buyer can understand how they would be charged and how risk is allocated without a sales call, which is more than most vendors here offer, but not the rate.

Coverage is stated per program and has broadened quickly: musculoskeletal care through Thrive, women's health through Bloom, and cardiometabolic care through Pulse, announced for later 2026. Held back from A because the expansion is recent and Pulse is not yet generally available, so validated coverage is narrower than the marketed range. Buyers should confirm which programs are live for their population.